{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Possibly Marketed Outside US
Source:
21 CFR 352
(2017)
Source URL:
First approved in 2012
Source:
Zithranol by Elorac Inc.
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
Vetericyn FoamCare by Innovacyn Inc.
(2016)
Source URL:
First approved in 2012
Source:
21 CFR 333E
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
Confidence 1-3 RTU by Universal
(2012)
Source URL:
First approved in 2012
Source:
Confidence 1-3 RTU by Universal
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
21 CFR 333D
(2012)
Source URL:
First approved in 2012
Source:
21 CFR 333D
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
21 CFR 352
(2012)
Source URL:
First approved in 2012
Source:
21 CFR 352
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
Ultimate P.D. Concentrate by Ecolab Inc.
(2012)
Source URL:
First approved in 2012
Source:
Ultimate P.D. Concentrate by Ecolab Inc.
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
Ultra Omega 3 by Liberty Bioscience LLC
(2017)
Source URL:
First approved in 2012
Source:
Super Omega 3 by 3T Federal Solutions LLC
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
Super Omega 3 by 3T Federal Solutions LLC
(2012)
Source URL:
First approved in 2012
Source:
Super Omega 3 by 3T Federal Solutions LLC
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
21 CFR 352
(2012)
Source URL:
First approved in 2012
Source:
21 CFR 352
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
First approved in 2012
Source:
Unapproved drug other
Source URL:
Class:
MIXTURE